ResearcherUniversity of PittsburghActive in the last 2 years
Anna E. Lokshin
Matched on ORCID iD 0000-0001-8171-220X; OpenAlex author ID A5071827985; NIH RePORTER profile ID 1873927. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 2)
- Trials
- 0
- Grants
- 2
- Labs led
- 1
- Collaborators
- 20
2011: 2 papers · 2012: none · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 grant · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 grant
Papers 4
- A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9 alone. Co-author DOI 10.1016/j.canlet.2024.217245↗
- Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. Last author DOI 10.1371/journal.pone.0094928↗
- Serum biomarker panels for the detection of pancreatic cancer. Last author DOI 10.1158/1078-0432.ccr-10-0248↗
- -The advancement of biomarker-based diagnostic tools for ovarian, breast, and pancreatic cancer through the use of urine as an analytical biofluid. First author DOI 10.5301/jbm.2011.8613↗
Grants 2
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Randall E. Brand · 3 shared papers, 1 shared grant, 2011–2025 · strength 1.08
- Grant Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer R01CA254036↗
- Paper A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9… DOI 10.1016/j.canlet.2024.217245↗
- Paper Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. DOI 10.1371/journal.pone.0094928↗
- Surinder K. Batra · 1 shared paper, 1 shared grant, 2024–2025 · strength 1.01
- Christine Worthington · 1 shared paper, 2024 · strength 0.16
- Lynette M. Smith · 1 shared paper, 2024 · strength 0.16
- Ben Staal · 1 shared paper, 2024 · strength 0.16
- Johannes Francois Fahrmann · 1 shared paper, 2024 · strength 0.16
- Samir Hanash · 1 shared paper, 2024 · strength 0.16
- Anirban Maitra · 1 shared paper, 2024 · strength 0.16
- Maneesh Jain · 1 shared paper, 2024 · strength 0.16
- Brian B. Haab · 1 shared paper, 2024 · strength 0.16
- Sushil Kumar K · 1 shared paper, 2024 · strength 0.16
- Ying Huang · 1 shared paper, 2024 · strength 0.16
- Brian M. Nolen · 3 shared papers, 2011–2014 · strength 0.12
- Paper -The advancement of biomarker-based diagnostic tools for ovarian, breast, and pancreatic cancer through the use of urin… DOI 10.5301/jbm.2011.8613↗
- Paper Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. DOI 10.1371/journal.pone.0094928↗
- Paper Serum biomarker panels for the detection of pancreatic cancer. DOI 10.1158/1078-0432.ccr-10-0248↗
- Herbert J. Zeh · 2 shared papers, 2011–2014 · strength 0.06
- Peter J. Allen · 2 shared papers, 2011–2014 · strength 0.06
- Selwyn Maurice Vickers · 1 shared paper, 2011 · strength 0.02
- Mohamad A. Eloubeidi · 1 shared paper, 2011 · strength 0.02
- John D. Christein · 1 shared paper, 2011 · strength 0.02
- J. Pablo Arnoletti · 1 shared paper, 2011 · strength 0.02
- David Clement Whitcomb · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.